CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 83 filers reported holding CYTOSORBENTS CORP in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $20 | -99.9% | 1,687 | +16.0% | 0.00% | – |
Q3 2022 | $17,000 | 0.0% | 1,454 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $17,000 | 0.0% | 1,454 | 0.0% | 0.00% | – |
Q1 2022 | $17,000 | – | 1,454 | – | 0.00% | – |
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2020 | $16,000 | 0.0% | 1,967 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $16,000 | – | 1,967 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2018 | $6,000 | -82.9% | 430 | -92.3% | 0.00% | -100.0% |
Q3 2017 | $35,000 | +45.8% | 5,600 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $24,000 | -4.0% | 5,600 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $25,000 | -19.4% | 5,600 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $31,000 | -13.9% | 5,600 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $36,000 | +44.0% | 5,600 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $25,000 | -19.4% | 5,600 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $31,000 | – | 5,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
Avenir Corp | 190,240 | $1,517,000 | 0.16% |
Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
Olympiad Research LP | 17,816 | $142,000 | 0.07% |
HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |